ABSTRACT Leptin, 167 
beginning of the experiment to collect the gastric juice for analysis. The juice was analysed to determine its volume, pH, free and total acid concentration (FAC and TAC), proteolytic activity and mucin concentration. Lesions of gastric mucosa were scored, the ulcer index (UI) and preventive index (PI) were calculated. Gastric mucosa was scrapped and stored at -80 o C until used for assay of gastric mucosal prostaglandin E 2 (PGE 2 ). Exposure to CRS significantly reduced gastric juice volume, pH and mucin concentration and gastric mucosal PGE
and significantly increased gastric juice proteolytic activity and acidity (FAC and TAC) 8 . Leptin, a 167 amino acid peptide hormone, is secreted by the adipocytes into the circulation, lowers the body weight by decreasing appetite and increasing energy expenditure 9-11 . It has also been found to be present in the gastric mucosa 12 , and this has been thought to control food intake in humans. Another way of interpreting the presence of leptin in the gastric mucosa is to invoke its ability to function as a mucosal defence factor in the stomach. Brzozowski et al. (1999) 4 showed that leptin has a gastro-protective effect in rats.
Erkasap et al. 13 showed that leptin has a gastro-protective effect on mucosal injury induced by ischemia reperfusion. To date, there is a dearth of information about the mechanism by which leptin prevents ulcer formation in the stomach.
The aim of the present study was to investigate the effect of leptin on ulcer formation induced by cold restraint stress (CRS) and to study the role of leptin in relation to the established anti-ulcer agents such as famotidine.
MATERIALS & METHODS
Thirty six male albino rats weighing 150-200 grams were fed standard commercial rat chow with free access to water in mesh bottomed cages to minimize coprophagia and were left to acclimatize to laboratory conditions for 2 weeks prior to involvement in the experiment. Rats were fasted for 24 hours prior to the experiment. Except for the last hour, water was supplied ad libitum 14 . Rats were randomly classified into the following groups of six rats each: 1. Control non-stressed group (C); in which rats were left freely wandering in their cages after being subjected to pyloric ligation. in which indomethacin was administered in a dose of 10 mg/kg SC. This dose inhibits prostaglandin synthesis but does not induce gastric ulceration. Leptin (10 g/kg, SC) was given 30 minutes after indomethacin and rats were subjected to pyloric ligation and CRS. Three hours after pyloric ligation, rats were decapitated and their stomachs were removed, opened along the greater curvature and the gastric juice was collected and centrifuged for 15 minutes at 3000 rpm to remove any solid debris. Finally, each stomach was rinsed in ice cold saline and scored for macroscopic gross mucosal lesions by an observer not aware of the nature of the experiment. Gastric mucosa was washed with indomethacin (10 g/ml), scraped and stored at -80 o C until used for determination of its prostaglandin (PGE 2 ) content.
Assessment of Gastric Mucosal Lesions:
This was expressed in terms of ulcer index (UI) according to the method of Robert et al. 16 . The preventive index (PI) was calculated from the equation according to Hano et al. 17 .
Analysis of Gastric Juice:
The volume of clear supernatant was determined and analysed for these parameters: 
Statistical Analysis of Data:
Data were expressed as mean ± standard error of the mean (M ± SEM). Statistical significance of differences between groups were evaluated by unpaired two-tailed student's "t" test. Values of p  0.05 were considered statistically significant. 2 in the gastric mucosa in L group compared with CRS and C groups, while famitodine, L-NAME and indomethacin failed to produce significant change of PGE 2 in gastric mucosa of F, L-NAME and I groups in comparison to CRS group.
RESULTS

Effect of CRS on Gastric
Effect of CRS on Gastric Mucosal Lesion Development And Its Modulation By Famotidine, L-NAME And Indomethacin In Male Albino Rats:
CRS induced ulcerative lesions development in the gastric mucosa of all rats achieving an UI of 19.25 in CRS group. Both leptin and famotidine exhibited profound protection of the gastric mucosa achieving an UI of 9.5 and 9.75 in L and F groups respectively. This was evident also from the PI, which was 50.65 and 49.35 in L and F groups respectively. On the other hand, administration of L-NAME or indomethacin aggravated gastric mucosal ulcerative lesions achieving an UI of 10.75 and 14 in L-NAME and I groups respectively. 
DISCUSSION
Leptin is a peptide produced by adipocytes and regulates the function of the satiety center in the hypothalamus 9 . Although it has also been found in stomach
12
, its function in the stomach is not clear. In the current study, the property of leptin as an ulcer preventing agent was investigated. The results of the present study showed that exogenous leptin demonstrated profound ulcer preventing ability in rats when their gastric mucosa was exposed to ulcer inducing agents, such as stress. The basal leptin concentration did not prevent by itself the ulcerogenic effect of stress exposure. However, the exogenously administered leptin prevents that effect, indicating a pharmacological action of leptin.
Cold restraint stress (CRS) is a well-known ulcerogenic procedure. In thepresent study, CRS produced hemorrhagic lesions in the gastric mucosa three hours after its induction, which is in agreement with previous reports 22, 23 .
The pathogenic mechanisms responsible for stressinduced gastric mucosal lesions include disturbance of gastric mucosal microcirculation and abnormal gastric motility 24 . The rate of gastric secretion is linearly correlated with mucosal blood flow
25
. In the current investigation, CRS reduced significantly the volume of gastric secretion. This is likely to be due to reduced gastric mucosal blood flow, as reported by Murakami et al. 2 rather than direct inhibition of secretion.
CRS was observed, in the present study, to increase significantly both FAC and TAC with subsequent decrease in the pH of gastric juice that may be explained by the increased vagal discharge to the stomach induced by exposure to stress 2 . Leptin demonstrated profound ulcer prevention ability, which was compared well with that of famotidin when CRS was employed as an ulcerogenic model. Such finding is in line with Brzozowiski et al. 4 who reported that leptin has gastroprotective effect on mucosal injury induced by topical application of 75% ethanol.
The profound effect of inhibiting CRS ulcer formation exhibited by leptin was maintained, even when the animals were pre-treated with low dose of indomethacin. However, a competition in the production of gastric mucosal PGE 2 between indomethacin (inhibitor) and leptin (inducer) can not be ruled out. In CRS-induced ulceration, evaluation of the effect of leptin on gastric mucosal PGE 2 synthesis revealed an increase of gastric mucosal PGE 2 concentration, as reported in the present study and supported by another study
26
. This finding suggests that leptin might act, at least in part, via the cyclooxygenase pathway in preventing gastric CRS-induced ulceration. Furthermore, the results of the current investigation that leptin stimulated mucus secretion support the notion that this peptide acted by stimulating PGE 2 production.
It has been reported previously that PGE 2 stimulate mucus secretion 26- 28 . In contrast to the results of the present investigation, Brzozowiski, et al. 4 , reported that PGE 2 is not involved in the gastroprotective effect of leptin. The contradictory finding observed in the present results could be due to methodological difference in ulcer induction.
The results of the current study clearly demonstrated that leptin at dose level of 10 g/kg inhibited gastric acid secretion (both FAC and TAC), a result which is in accordance with that of Konturak et al. 29 , who have investigated the effect of leptin on gastric acid secretion using H. pylori positive and negative patients and reported that gastric meal and CCK-induced leptin is capable of inhibiting basal and meal-stimulated gastric acid secretion in H pyloripositive patients. But in H pylori negative patients, the release of leptin was reduced in response to CCK and meal.
Pre-treatment of animals with L-NAME (25mg/kg, SC), an inhibitor of nitric oxide synthase before exposure to stress, reduced peptic ulcer prevention ability of leptin significantly. This finding suggests that peptic ulcer preventing ability of leptin does not depend solely on the nitric oxide pathway. This again is in line with observation of Brzozowiski et al. 4 , that L-NAME reduced the ulcer preventing ability of leptin against acidified ethanol. Brzozowiski et al. 30 have also investigated the effect of centrally and intra-peritoneal administered leptin and reported that its gastro-protective action, accompanied by increased gastric blood flow and increased plasma gastrin levels, depends on vagal activity and involves hyperemiamediated by NO.
The results of the current study may have consequences for the clinical practice. Based on these data, one would want to recommend the use of leptin SC in a pilot study in humans, in order to access its efficacy as an ulcer prevention drug in patients in the intensive care units, who are more prone to develop stress ulcer 31 
.
In conclusion, leptin at a dose of 10 µg/kg, could have an ulcer preventing ability, which is comparable to that of famotidine, an H 2 antagonist. The ulcer prevention ability of leptin on CRS-induced ulcer may involve the cyclooxygenase and nitric oxide pathways. 
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